Last reviewed: June 9, 2026
Last updated: June 9, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide weight loss treatment begins at a starter dose and gradually increases every 4 weeks until you reach the dose that delivers consistent results for your body. Unlike many providers who charge more as doses climb, PlexusDx offers flat-rate pricing so your cost remains stable whether you stay at 0.5 mg or reach 2.4 mg weekly.
Understanding Semaglutide Dosing: Why Start Low and Go Slow?
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes management; the weight loss effect became evident during clinical trials where patients on higher doses lost significantly more weight than placebo groups. Starting at a lower dose (typically 0.25 mg) allows your digestive system and appetite-signaling pathways to adapt gradually, reducing nausea and other side effects that can lead to treatment discontinuation. Each week, your dose stays the same; then after 4 weeks, your prescriber evaluates your progress and tolerability before recommending the next dose step.
The typical semaglutide escalation schedule moves from 0.25 mg to 0.5 mg to 1.0 mg to 1.7 mg to 2.4 mg, with each step occurring roughly every 28 days if tolerated well. Research shows that most patients experience meaningful weight reduction in the 1.7–2.4 mg range, though some reach their target weight loss goal at lower maintenance doses. PlexusDx works with you to find the lowest effective dose that produces your desired results, supporting both your health outcomes and your long-term adherence to treatment.
How Your Individual Biology Determines Your Ideal Semaglutide Dose
Your genetics play a direct role in how your body responds to semaglutide and at what dose you'll see the best results. The GLP-1 receptor gene variant (rs6923761) and the FTO obesity-risk variant (rs9939609) influence how strongly your appetite control pathways respond to GLP-1 activation, meaning two patients at the same body weight may need different doses to achieve similar weight loss. PlexusDx Precision Peptide Genetic Test maps 14 peptide pathways and 49 distinct peptides, revealing your genetic predispositions to GLP-1 sensitivity, insulin response patterns, and metabolic rate—insights that inform your personalized dosing strategy from day one.
Beyond genetics, factors like your baseline weight, metabolic rate, liver and kidney function, and any other medications you take all influence how quickly you should escalate your dose and whether you might benefit from staying at a lower maintenance level. Your PlexusDx provider reviews these factors during your initial consultation and ongoing check-ins, ensuring your dose progression aligns with your medical history and treatment goals rather than a one-size-fits-all protocol.
The Real Cost of Semaglutide: Why PlexusDx Pricing Won't Change as Your Dose Increases
Many weight loss clinics charge more per dose as you move up the escalation ladder, meaning a patient who needs to reach 2.4 mg pays substantially more than someone who maintains 0.5 mg—even though they're both on the same medication from the same pharmacy. PlexusDx compounded semaglutide injection starts at $149 per month and remains flat across all dose levels, reflecting the principle that your dose may need to go up, but your price won't. This transparent pricing model removes a significant barrier to reaching your optimal therapeutic dose without financial anxiety.
PlexusDx semaglutide is compounded by licensed 503A pharmacies and available in all 50 states with no insurance requirement and no membership fee. Your prescription is HSA and FSA eligible, and if you want to add the Precision Peptide Genetic Test ($99 after your first month of treatment), you receive detailed genetic insights into your peptide-pathway response to personalize your dosing even further. This combination of affordability, accessibility, and genetic precision makes finding your ideal dose straightforward and economical.
What to Expect During Your Semaglutide Dose Escalation Timeline
Week 1–4: You start on 0.25 mg once weekly via injection. Most patients experience mild appetite suppression and may notice a slight decrease in food cravings; some report mild nausea, particularly if they eat large or fatty meals. Staying hydrated and eating smaller, protein-rich meals during this phase supports tolerability and helps your body adjust to the medication's effects on stomach emptying and satiety signaling.
Week 5–12: Your dose increases to 0.5 mg weekly (assuming you tolerated the starter dose well). By week 8, many patients report more noticeable appetite reduction and begin seeing weight loss on the scale; this is typically when you'll discuss your progress with your PlexusDx provider and plan the next dose increase. Week 13 onward: Subsequent escalations to 1.0 mg, 1.7 mg, and potentially 2.4 mg occur every 4 weeks if tolerated, with regular check-ins to monitor side effects, weight loss velocity, and whether your current dose is delivering the results you and your provider have agreed upon.
Throughout this timeline, your PlexusDx monthly cost remains the same regardless of which step you're on, allowing you to focus on your health progress rather than budget concerns. If you experience intolerable side effects, your provider can pause escalation or adjust your timing, keeping you on a dose that feels sustainable and safe.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the standard starting dose of semaglutide for weight loss?
The standard starting dose is 0.25 mg once per week via subcutaneous injection. This low starter dose allows your body to adapt to the medication's appetite-suppressing effects while minimizing nausea and other side effects that could interfere with treatment adherence.
How much weight can I expect to lose at each semaglutide dose level?
Clinical trials show that patients on 1.7 mg and 2.4 mg lose approximately 10–15% of their body weight over 68 weeks, compared to 2–3% with placebo. Individual results vary based on genetics, diet, exercise, and how your body responds; some patients reach their goal weight at lower doses while others benefit from the full 2.4 mg maintenance dose.
Does PlexusDx charge more as my semaglutide dose increases?
No. PlexusDx compounded semaglutide injection starts at $149 per month and remains flat across all dose levels, regardless of whether you escalate from 0.25 mg to 2.4 mg. Your dose may need to go up, but your price won't.
What side effects should I expect during dose escalation, and when do they improve?
Common side effects during dose escalation include nausea, mild constipation, and reduced appetite. These effects typically peak 1–2 weeks after a dose increase and improve by week 3–4 as your body adapts. If side effects persist or worsen, talk to your PlexusDx provider about slowing your escalation timeline or adjusting your meal patterns.
How does the Precision Peptide Genetic Test help me find the right semaglutide dose?
PlexusDx Precision Peptide Genetic Test analyzes variants in your GLP-1 receptor gene (rs6923761), FTO gene (rs9939609), and 47 other peptide-related variants across 14 pathways. These insights reveal your genetic predisposition to GLP-1 sensitivity, helping your provider predict whether you'll respond strongly at lower doses or may need to escalate further, personalizing your treatment from the start.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Lab Tests to Expect While on GLP-1 Medications
Is Compounded Semaglutide the Same as Mounjaro?